120 related articles for article (PubMed ID: 1631251)
21. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia.
Peters JR; Rodriguez-Arnao MD; Foord SM; Edwards C; Dieguez C; Woodhead S; Hall R; Scanlon MF
J Endocrinol Invest; 1985 Apr; 8(2):163-6. PubMed ID: 4031383
[TBL] [Abstract][Full Text] [Related]
22. Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms.
Johnstone EC; Crow TJ; Mashiter K
Psychol Med; 1977 May; 7(2):223-8. PubMed ID: 877185
[TBL] [Abstract][Full Text] [Related]
23. Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Davis BM; Davis KL; Mohs RC; Mathé AA; Rothpearl AB; Johns CA; Levy MI; Horvath TB
Arch Gen Psychiatry; 1985 Mar; 42(3):259-64. PubMed ID: 3977547
[TBL] [Abstract][Full Text] [Related]
24. Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.
de Mey C; Enterling D; Meineke I; Yeulet S
Br J Clin Pharmacol; 1991 Oct; 32(4):483-8. PubMed ID: 1683559
[TBL] [Abstract][Full Text] [Related]
25. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
26. Plasma prolactin concentrations and psychopathology in chronic schizophrenia.
Kleinman JE; Weinberger DR; Rogol AD; Bigelow LB; Klein ST; Gillin JC; Wyatt RJ
Arch Gen Psychiatry; 1982 Jun; 39(6):655-7. PubMed ID: 6979991
[TBL] [Abstract][Full Text] [Related]
27. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
[TBL] [Abstract][Full Text] [Related]
28. Increased thyrotrophin and prolactin secretion induced by domperidone in hypothyroid subjects.
Massara F; Camanni F; Amoroso A; Molinatti GM; Müller EE
Acta Endocrinol (Copenh); 1981 May; 97(1):48-53. PubMed ID: 7223316
[TBL] [Abstract][Full Text] [Related]
29. Acute elevation of endogenous prolactin does not influence glucose homeostasis in healthy men.
Vigas M; Klimes I; Jurcovicová J; Jezová D
Physiol Res; 1993; 42(5):341-5. PubMed ID: 8130181
[TBL] [Abstract][Full Text] [Related]
30. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
[TBL] [Abstract][Full Text] [Related]
31. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
[TBL] [Abstract][Full Text] [Related]
32. Prolactin bioassay in schizophrenia before and after neuroleptics.
Peabody CA; Warner MD; Griffin M; Boutros NN; Worsley IG; Friesen HG
Psychiatry Res; 1992 Mar; 41(3):249-55. PubMed ID: 1594711
[TBL] [Abstract][Full Text] [Related]
33. Domperidone stimulates prolactin secretion in rats with complete destruction of the mediobasal hypothalamus.
Kiem DT; Nagy GM; Barna I; Makara GB
Brain Res Bull; 1997; 44(2):151-4. PubMed ID: 9292204
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
35. Naloxone in chronic schizophrenic patients: neuroendocrine and behavioral effects.
Kleinman JE; Weinberger DR; Rogol A; Shiling DJ; Mendelson WB; Davis GC; Bunney WE; Wyatt RJ
Psychiatry Res; 1982 Aug; 7(1):1-7. PubMed ID: 6127744
[TBL] [Abstract][Full Text] [Related]
36. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
Sowers JR; Eggena P; Phillips D
Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
[TBL] [Abstract][Full Text] [Related]
37. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
[TBL] [Abstract][Full Text] [Related]
38. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal instability of hormone responses in schizophrenia.
Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):545-9. PubMed ID: 6686692
[TBL] [Abstract][Full Text] [Related]
40. Serum prolactin, psychopathology, and ventricular size in chronic schizophrenia.
Luchins DJ; Robertson AG; Meltzer HY
Psychiatry Res; 1984 Jun; 12(2):149-53. PubMed ID: 6147869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
